BPA for anascorp
Active Awarded Last action
- Contract number
- 36E79723A0014
- Awardee
-
Rare Disease Therapeutics, Inc. UEI M7B1ABSZJKX8
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 85% complete
- IDV ceiling
- $250,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
Rare Disease Therapeutics, Inc., a woman-owned small business headquartered in Franklin, Tennessee, was awarded a single-award Blanket Purchase Agreement by the Department of Veterans Affairs National Acquisition Center on June 1, 2023, with a ceiling value of $250,000 and an ultimate completion date of May 31, 2027. The BPA is structured as a firm fixed-price contract under the company's General Services Administration Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB) and carries no set-aside designation. The contract serves as an indefinite delivery vehicle that provides the VA with access to Rare Disease Therapeutics' specialized pharmaceutical catalog, with particular emphasis on orphan drugs and rare disease treatments intended to support the Department's clinical and medical countermeasure requirements across its healthcare network.
The contract enables the VA to issue delivery orders for specialty pharmaceutical products from Rare Disease Therapeutics' inventory, leveraging the vendor's established expertise in distributing high-value, low-volume pharmaceutical products to federal healthcare agencies. While the specific places of performance were not delineated in the contract documentation, the vendor's operational focus and historical performance record indicate capability to serve VA medical facilities nationwide. The underlying GSA Schedule contract mechanism provides the VA with streamlined procurement authority to obtain these specialized products on an as-needed basis, without requiring separate full and open competition for individual orders, thereby supporting continuity of access to critical pharmaceutical therapeutics for the Department's beneficiary population.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79723A0014?
36E79723A0014 was awarded to Rare Disease Therapeutics, Inc. by National Acquisition Center (Headquarters) on June 1, 2023.
How much is contract 36E79723A0014 worth?
36E79723A0014's own ceiling is $250,000.
Who can order from contract 36E79723A0014?
36E79723A0014 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79723A0014 under another contract?
Yes. 36E79723A0014 is a blanket purchase agreement under 36F79718D0404, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79723A0014 competed?
The extent of competition for 36E79723A0014 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV